AstraZeneca
Making NF1 better understood
For the NF1 awareness day in Casablanca, we supported AstraZeneca and the Moroccan Neurofibromatosis Association with press coordination, bilingual material and an awareness podcast, followed by media coverage of the issues raised.
- Where
- Casablanca, Morocco
- When
- May–June 2026
- Our role
- Media relations & awareness content
- With AstraZeneca and AMNF
Our role
We supported the event’s media coordination and bilingual communication, alongside photography, video and an awareness podcast.
Explore the outcomeA longer conversation
The awareness podcast with Maha Chraibi and AMNF’s president.
Press + broadcast
Coverage of the issues raised
Written reporting alongside television and radio coverage.
Awareness podcast
A longer-form discussion
A programme with Maha Chraibi and expert and association voices.
The situation
On 17 May 2026, AstraZeneca and the Moroccan Neurofibromatosis Association brought patients, families and health professionals together in Casablanca. The discussion concerned recognition of neurofibromatosis as a chronic condition and more equitable access to care.
We supported the communication around the event. Our remit included press invitations and on-site media coordination, French and Arabic press material, photography and video, and an awareness podcast. The subject needed explanation for people outside a specialist medical audience, while keeping the association’s concerns visible.
Explain the issue through both press reporting and a longer conversation.
The approach
The programme used different formats to explain the same subject. Written press material set out the event and the call for recognition. A podcast with Maha Chraibi and expert and association voices allowed more time for discussion than a short announcement.
We coordinated that content with the event’s press activity. The release went through AstraZeneca and association approval before distribution. This kept the public information tied to the organisations involved, while journalists could choose how to address the issue for their own audiences.
The work
We handled invitations and media coordination on site, prepared French and Arabic releases and followed their publication. Photography, video and the awareness podcast formed part of the delivered programme.
We also pitched the subject to broadcast media and followed the published reporting. The media debrief brought together press coverage and podcast reporting, giving the client a view of how the subject had appeared across the different formats.
What we delivered
Bilingual press materials
French and Arabic releases with client and association approval.
Event media support
Invitations, on-site coordination and coverage follow-up.
Awareness content
Photography, video and podcast production.
Enlarge excerptThe issue presented to the press
The client-approved release sets out AMNF’s call for better recognition of neurofibromatosis and more equitable access to care. The excerpt shows the headline and opening paragraph of the distributed document.
View the publicationThe outcome
The story appeared in written, podcast and broadcast formats. Le360’s article on 19 May explained the association’s call for recognition as a long-term condition and the difficulties families faced in accessing care. The delivered reporting also documented television and radio coverage alongside the awareness content.
These outputs extended the discussion beyond the people attending the event. The written reporting set out the association’s concerns, while the longer-form awareness content gave expert and association voices more time to explain the subject. Our work connected that content with press outreach and follow-up.
The story in public.
Selected reporting and announcements from the project.

